CoChat

No evidence of an increase in early infant mortality from congenital adrenal hyperplasia in the absence of screening

Hird, B. E., Tetlow, L., Tobi, S., Patel, L., Clayton, P. E. · 2014 · Archives of Disease in Childhood

The DOI matches its Crossref record; 39 of the 42 references it cites were found in a registry or an index.

Abstract

OBJECTIVE: Congenital adrenal hyperplasia (CAH) is not currently included in the UK newborn screening programme. We investigated the hypothesis that, owing to non-specificity of symptoms, a proportion of males affected by salt-wasting (SW) CAH have died in infancy without being diagnosed. DESIGN: Stored newborn screening blood spot samples were analysed for 17α-hydroxyprogesterone (17-OHP) in the following groups: Infants born in the North West of England, 1994 to 2006, who had died by 6 months age; (n=1198), a neonatal reference group (full-term n=100; preterm n=100) and a CAH positive control group. A newborn blood spot sample collected before diagnosis was available in 29/61 CAH patients recruited. SW CAH was present in 18/29 patients (16 males and 2 females). Samples from the deceased group with elevated 17-OHP were analysed for 8 common mutations in the 21-hydroxylase gene (CYP21A2). SETTING: North West of England. RESULTS: Grouped by gestational age, mean (maximum) blood spot 17-OHP in nmol/L was as follows. Deceased full-term n=279, 6 (107); deceased premature n=365, 28 (251); deceased unknown gestational age n=553, 13 (>394). In the SW positive control group, the lowest level of 17-OHP was 179 nmol/L and 14 had levels greater than the highest standard (>268 to >420 nmol/L). All samples from the deceased group with 17-OHP results >179 nmol/L (n=6) and a further 13 samples underwent mutation analysis. No mutations were identified. CONCLUSIONS: Our findings do not support the hypothesis that, in our unscreened population, males affected by SW CAH are dying prior to diagnosis.

Overview

Integrity signals

Registry

Crossref · 10.1136/archdischild-2013-304473

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 39 references

Cited by

See all 25

Metadata

Authors
Hird, B. E., Tetlow, L., Tobi, S., Patel, L., & Clayton, P. E.
Affiliations
  • Royal Manchester Children's Hospital (GB)
  • Manchester Academic Health Science Centre (GB)
Corresponding author
Hird, B. E.
Venue
Archives of Disease in Childhood
Publisher
BMJ
Published
2013-11-13
Volume
99
Issue
2
Pages
158-164
ISSN
  • 0003-9888 (ISSN-L)
  • 1468-2044
OpenAlex
W2131240932
Cited by
25
References
42
Citations by year
2026: 2 · 2024: 1 · 2023: 1 · 2022: 1 · 2021: 6 · 2020: 3 · 2019: 1 · 2018: 1 · 2016: 2 · 2015: 4 · 2014: 3
FWCI
1.34
Type
journal article
Language
en
Open access
closed
Locations
  • Archives of Disease in Childhood (publishedVersion)
  • PubMed (publishedVersion)
  • Research Explorer (The University of Manchester) (submittedVersion)
  • HighWire Press Open Archive (submittedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
Keywords
congenital adrenal hyperplasia, salt-wasting CAH, newborn screening, 17-hydroxyprogesterone, CYP21A2 mutations, undiagnosed disease, preterm infants
MeSH terms
Adrenal Hyperplasia, Congenital, DNA Mutational Analysis, England, Female, Humans, Infant, Infant, Newborn, Male, Retrospective Studies, Neonatal Screening, Point Mutation, 17-alpha-Hydroxyprogesterone

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: No evidence of an increase in early infant mortality from congenital adrenal hyperplasia in the absence of screening. https://app.cochat.ai/papers/10.1136/archdischild-2013-304473
The paper
Hird, B. E., Tetlow, L., Tobi, S., Patel, L., & Clayton, P. E. (2014). No evidence of an increase in early infant mortality from congenital adrenal hyperplasia in the absence of screening. Archives of Disease in Childhood. https://doi.org/10.1136/archdischild-2013-304473

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.